DrugPatentWatch Database Preview
Details for Patent: 5,965,525
Email this page to a colleague
See Plans and PricingWhich drugs does patent 5,965,525 protect, and when does it expire?
Patent 5,965,525 protects ERAXIS and is included in one NDA.
This patent has forty-four patent family members in twenty-six countries.
Summary for Patent: 5,965,525
| Title: | Cyclic peptide antifungal agents |
| Abstract: | Provided are compounds of the formula (1): ##STR1## wherein R' is hydrogen, methyl or NH.sub.2 C(O)CH.sub.2 --; R" and R'" are independently methyl or hydrogen; R and R.sup.y are independently hydroxy or hydrogen; R.sub.1 is hydroxy, hydrogen, or hydroxysulfonyloxy; R.sub.7 is hydroxy, hydrogen, hydroxysulfonyloxy or phosphonooxy; R.sub.2 is a novel acyl side chain. Also provided are novel formulations, methods of inhibiting fungal and parasitic activity, and a process for preparing dideoxy (R=H) forms of the compounds. |
| Inventor(s): | Burkhardt; Frederick J. (Indianapolis, IN), Debono; Manuel (Indianapolis, IN), Nissen; Jeffrey S. (Indianapolis, IN), Turner, Jr.; William W. (Bloomington, IN) |
| Assignee: | Eli Lilly and Company (Indianapolis, IN) |
| Application Number: | 08/449,056 |
|
Patent Claim Types: see list of patent claims | Compound; Use; Composition; Formulation; |
Drugs Protected by US Patent 5,965,525
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vicuron | ERAXIS | anidulafungin | POWDER;INTRAVENOUS | 021632-001 | Feb 17, 2006 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | TREATMENT OF FUNGAL INFECTIONS | Start Trial | ||
| Vicuron | ERAXIS | anidulafungin | POWDER;INTRAVENOUS | 021632-002 | Nov 14, 2006 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | TREATMENT OF FUNGAL INFECTIONS | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,965,525
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 217635 | Start Trial | |||
| Australia | 3534193 | Start Trial | |||
| Australia | 6552996 | Start Trial | |||
| Australia | 689391 | Start Trial | |||
| Brazil | 1100417 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
